Issues relating to prequalified vaccines
Information concerning issues relating to prequalified vaccines can be found at the links below.
-
Information on a voluntary suspension, temporarily and as a precautionary measure, of distribution of a prequalified typhoid vaccine produced by Sanofi Pasteur
12 July 2013 -
Quality and Safety of Quinvaxem (DTwP-HepB-Hib) pentavalent vaccine
5 July 2013 -
Update on two-dose presentation of preservative-free Human Papilloma Vaccine from GlaxoSmithKline (GSK) (Cervarix™)
6 February 2013 -
Suspension of Statens Serum Institute IPV supply through UN procurement
29 November 2012 -
Update on two-dose presentation of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™)
14 May 2012 -
Bharat Biotech monovalent hepatitis B vaccine and oral polio vaccines delisted from WHO prequalification list
1 May 2012 -
Lifting of suspension of supply of vaccines manufactured by BB-NCIPD, Bulgaria and distributed by Intervax
28 March 2012 -
Panacea OPV delisted from WHO's prequalified vaccines list
27 February 2012 -
Suspension of supply of through UN of hepatitis B vaccine (Revac-B+) manufactured by Bharat Biotech International Limited and termination of prequalification procedures for current applications for other vaccines from Bharat Biotech International Limited
5 December 2011 -
Panacea Biotec DTP-based combination and monovalent hepatitis B vaccines delisted from WHO list of prequalified vaccines
17 August 2011 -
GlaxoSmithKline's Pandemrix vaccine and cases of narcolepsy
27 July 2011 -
Supply of WHO-prequalified vaccines containing DTwP antigens manufactured by Novartis Vaccines, Germany
12 July 2011 -
Vaccine quality investigation of Quinvaxem (DTwP-hepatitis B-Hib) vaccine, manufactured by Crucell N.V.
28 June 2011 -
Suspension of supply of vaccines manufactured by BB-NCIPD, Bulgaria and distributed by Intervax
28 April 2011 -
Recall and destruction of specific batches of yellow fever vaccine from Institut Pasteur, Dakar
15 December 2010 -
GlaxoSmithKline Biologicals' Arepanrix H1N1 vaccine delisted from the WHO list of prequalified vaccines
5 November 2010 -
Shantha Biotechnics (India) pentavalent vaccine, Shan5, delisted from the WHO list of prequalified vaccines
28 July 2010 -
DNA fragments of a porcine circoviruses in rotavirus vaccines
3 June 2010 -
Prequalification of one- and two-dose presentations of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™)
30 April 2010